$ARWR (-4.31%) | Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs
- Markets
- Stocks
- Arrowhead Pharms
- Forum Discussion
Arrowhead Pharms
Stock
Stock
ISIN: US04280A1007
Ticker: ARWR
US04280A1007
ARWR